Skip to main content

Table 2 HPV prevalence in participants from central Brazil

From: Prevalence, genotype profile and risk factors for multiple human papillomavirus cervical infection in unimmunized female adolescents in Goiânia, Brazil: a community-based study

 

HPV positive participants

Multiple HPV positive participants

n

% (95% CI)

n

% (95% CI)

HPV

121

28.0 (23.9-32.5)

54

100

One HPV type

67

15.5 (12.3-19.4)

-

-

Multiple HPV types

54

12.5 (9.6-16.1)

-

-

HR-HPV

107

24.8 (20.8-29.2)

53

98.1 (90.1-100.0)

LR-HPV

32

7.4 (5.2-10.4

19

5.8 (3.6-9.0)

HPV 16

29

6.7 (4.6-9.6)

21

38.9 (25.9-53.1)

HPV 51

22

5.1 (3.3-7.7)

18

33.3 (21.1-47.5)

HPV 31

20

4.6 (2.9-7.2)

12

22.0 (12.0-35.6)

HPV 52

18

4.2 (2.6-6.6)

10

18.5 (9.3-31.4)

HPV 18

15

3.5 (2.0-5.8)

12

22.2 (12.0-35.6)

HPV 53

11

2.5 (1.3-4.6)

11

20.4 (10.6-36.5)

HPV 58

10

2.3 (1.2-4.4)

8

14.8 (6.6-27.1)

HPV 39

9

2.1 (1.0-4,1)

8

14.8 (6.6-27.1)

HPV 6

7

1.6 (0.7-3.5)

6

11.1 (4.2-22.6)

HPV 45

6

1.4 (0.6-3.2)

1

1.9 (0.0-9.9)

HPV 66

6

1.4 (0.6-3.2)

3

5.6 (1.2-15.4)

HPV 73

6

1.4 (0.6-3.2)

2

3.7 (0.5-12.7)

HPV 42

5

1.2 (0.4-2.8)

3

5.6 (1.2-15.4)

HPV 54

5

1.2 (0.4-2.8)

2

3.7 (0.5-12.7)

HPV 26

4

0.9 (0.3-2.5)

2

3.7 (0.5-12.7)

HPV 33

4

0.9 (0.3-2.5)

3

5.6 (1.2-15.4)

HPV 56

4

0.9 (0.3-2.5)

2

3.7 (0.5-12.7)

HPV 68

4

0.9 (0.3-2.5)

3

5.6 (1.2-15.4)

HPV 40

3

0.7 (0.2-2.2)

1

1.9 (0.0-9.9)

HPV 84

3

0.7 (0.2-2.2)

3

5.6 (1.2-15.4)

HPV 35

2

0.5 (0.1-1.8)

2

3.7 (0.5-12.7)

HPV 70

2

0.5 (0.1-1.8)

0

-

HPV 55

2

0.5 (0.1-1.8)

1

1.9 (0.0-9.9)

HPV 61

2

0.5 (0.1-1.8)

0

-

HPV 62

2

0.5 (0.1-1.8)

2

3.7 (0.5-12.7)

HPV 59

1

0.2 (0.0-1.5)

1

1.9 (0.0-9.9)

HPV 82

1

0.2 (0.0-1.5)

1

1.9 (0.0-9.9)

HPV 11

1

0.2 (0.0-1.5)

0

-

HPV 89

1

0.2 (0.0-1.5)

1

1.9 (0.0-9.9)

HPV 44

1

0.2 (0.0-1.5)

0

-

  1. HPV: human papillomavirus; CI: confidence interval; n: number of participants; HR-HPV: high-risk HPV; LR-HPV: low-risk HPV.